Estimated Vaccine Effectiveness for Respiratory Syncytial Virus–Related Acute Respiratory Illness in Older Adults: Findings From the First Postlicensure Season

Journal:

Clinical Infectious Diseases

Published:

2025-10-21

DOI:

10.1093/cid/ciaf496

Affiliations:

9

Authors:

21

Go to article

Institutions	Authors	Share
Pfizer, United States of America (USA)	10.000000 10.000000	0.48
Kaiser Permanente Southern California, United States of America (USA)	9.500000	0.45
University of California, Berkeley (UC Berkeley), United States of America (USA)	1.000000	0.05
Kaiser Permanente Bernard J. Tyson School of Medicine, United States of America (USA)	0.500000	0.02

Interested in Medical Microbiology?